Stock Events

Stock Events

CytomX Therapeutics (6C1.F) Q2 2025 Earnings

12MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.18

-0.04

0.1

0.24

Details

Expected EPS

0.11242331464

Actual EPS

0.2433132

Surprise EPS

0.13

Surprise Percent

+116.43%

Description

CytomX Therapeutics (6C1.F) has reported earnings of 0.2433132 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.